Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
about
P1343
Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiationIntracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278FcDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analoguesMRP3, an organic anion transporter able to transport anti-cancer drugsMultidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogsABC transporters in fish species: a reviewCharacterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membranepABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cellsInhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transportRole of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cellsMechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletionCharacterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) geneMultidrug resistance associated protein 2 mediates transport of prostaglandin E2Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiationHigh-dose retinoic acid modulates rat calvarial osteoblast biology.Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts.Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistanceUsefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimusCranial sutures as intramembranous bone growth sites.Osseous tissue engineering in oncologic surgery.Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.Mechanisms and clinical implications of renal drug excretion.Role of N-cadherin in bone formation.Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.The role of drug efflux pumps in acute myeloid leukemia.Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins.Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitorPhotoaffinity labeling of the multidrug resistance protein 2 (ABCC2/cMOAT) with a photoreactive analog of LTC(4)The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugsDifferential effect of P-gp and MRP2 on cellular translocation of gemifloxacinCytokine therapy for craniosynostosis.Practical aspects of transporter model systems: a case study involving SQV.
P2860
Q24296414-5C91D7AE-FDBF-4892-BAA9-A8D4740D1298Q24297195-ACC0F8A2-D2C9-431E-BC0F-8F1F082EA5DFQ24314274-30D49613-3C46-46AB-A6E1-2AD3CC4B5996Q24533593-FC5BF160-2EA1-429D-AADC-DE6F5114ABF0Q24650550-33851552-C444-4DDE-9C97-7B0E43459898Q24681283-A83B47CC-1B9B-4A19-92E3-D5EFB1B6F387Q26823286-7C4A3F7B-8C24-44B8-A4A3-7665F0C3F595Q28139968-E88239B5-C3C0-47C2-9AF3-4BEA268366BFQ28141486-AE1C3EB9-7D9A-488C-B77E-B69C2EB2A623Q28344522-964B373A-2024-48E7-8EA2-CA8698E33456Q28362690-397D2CB0-2283-4E8A-950F-222AA9A49101Q28366592-AAB01F93-B0C5-4B8A-88CE-806D4C585A4AQ28371752-2D97A645-7D28-47E2-B5B0-0DA06AF7D66AQ28580790-F8F94B46-D672-4784-BEC8-A547C1C38840Q28593870-79770402-BC85-4634-BE1F-7589539C3745Q29465464-D5ED1132-1EA0-40FA-A850-8238F13D4670Q31948333-EB6A1954-0371-493F-BA41-6A9FE42B0526Q32063211-BBAE3978-BD45-414F-802C-166D0F3234E6Q33490314-5E4C6861-FC31-47E7-B858-CEFA12CABC15Q33614494-10B6A01F-94DA-441D-82AA-09564452B81DQ33798494-26D4FE6D-1E96-4E25-B7E0-B99770675954Q33938893-555BA59E-44B8-4AA0-A898-8DB3C3DD72E2Q33977234-21E387C8-1A72-4B20-91BB-4D2C91573FC0Q34085716-0C2BBA95-87CA-4B24-B37D-F47EAA97B246Q34117037-639E75B8-BBEB-4B33-8E7F-FEE977F5A520Q34124847-B1223DC0-C006-4827-8901-75F716218907Q34479011-BA060281-C88F-4F2C-A73F-1B3FA9549998Q34539995-43CFA009-1CBA-40F3-A792-EE8C88D2A17CQ34627891-E1E6C04A-43DC-420A-B3EC-B35658C8C3AAQ34761824-AA446FD2-C07B-40BF-A0AB-099987F50018Q34769834-EB8E757A-8A34-4611-B130-072BA7CE81E9Q34837480-86D4F3AD-0475-4793-9845-A21983BC0535Q34938668-A21E7340-A8D7-402C-9D8E-5C6D173BC6FEQ35042006-E40722A0-85AC-4A63-9407-1F0BAA82B231Q35196297-2B08E6E0-48A5-4597-9397-73687F96AABAQ35232228-30D0D006-BEA6-4CD8-A884-49775710F9C9Q35234371-38ACE41D-316D-4B57-80FC-F66E345BE979Q35374935-1C742D28-B5E9-42E8-90D8-0149323AB753Q35684846-D16FA6BD-592D-4E0D-A101-0CF73D84AA48Q35828049-4C840F2B-BD7A-474E-9512-B48F4A0BB799
P2860
Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@ast
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@en
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@nl
type
label
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@ast
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@en
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@nl
prefLabel
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@ast
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@en
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@nl
P2093
P2860
P356
P1476
Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA
@en
P2093
A H Schinkel
L van Deemter
R P Oude Elferink
P2860
P304
P356
10.1172/JCI119886
P407
P4510
P577
1998-04-01T00:00:00Z